ULTRAGENYX PHARMACEUTICAL INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.22 USD | -0.82% |
|
-4.58% | -13.80% |
| May. 03 | Wedbush Adjusts Ultragenyx Pharmaceutical's Price Target to $47 From $48, Keeps Neutral Rating | MT |
| May. 02 | Transcript : Ultragenyx Pharmaceutical Inc., Q1 2024 Earnings Call, May 02, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Bio Therapeutic Drugs | -0.82% | -4.58% | -13.80% | -12.43% | -34.00% | 3.42B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- RARE Stock
- Charts Ultragenyx Pharmaceutical Inc.
- Comparison Chart